Results 161 to 170 of about 27,602 (209)
Reactions Weekly, 2021 The development of low-molecular and ultra-low-molecular weight heparins has changed anticoagulation treatment options. Enoxaparin is a low-molecular weight heparin (LMWH), which works on Factor Xa and is indicated for both the prevention and treatment ...
Padayachee, N. +2 more
core +3 more sources
Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin
Pharmaceutics, 2020 Enoxaparin, an anticoagulant that helps prevent the formation of blood clots, is administered parenterally. Here, we report the development and evaluation of lipid–polymer hybrid nanoparticles (LPHNs) for the oral delivery of enoxaparin.
Bo Tang, Guihua Fang
exaly +3 more sources
Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
Thrombosis Research, 2021 International audiencePurposeIn intensive-care unit (ICU) patients, pathophysiological changes may affect thepharmacokinetics of enoxaparin and result in underdosing.
Paul Zufferey +2 more
exaly +2 more sources
Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism
Journal of Thrombosis and Haemostasis, 2017 Essentials In venous thromboembolism (VTE), it is uncertain if enoxaparin should be given twice or once daily. We compared the 15- and 30-day outcomes in VTE patients on enoxaparin twice vs. once daily.
J Trujillo-Santos +2 more
exaly +2 more sources
Journal of the American College of Cardiology, 2003 ObjectivesThis study was designed to assess whether use of enoxaparin during percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated heparin, in addition to background therapy with eptifibatide.BackgroundData supporting ...
Jeffrey A Breall
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical application of enoxaparin
Expert Review of Cardiovascular Therapy, 2004Low-molecular-weight heparins have several important advantages over unfractionated heparin (UFH). Due to a longer plasma half life together with high bioavailability and a linear dose-response relationship, the drugs can be safely and effectively administered in the hospital or ambulatory settings without the need to monitor the anticoagulant effect ...
openaire +2 more sources